Atria Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Buy |
5,472
+391
| +8% | +$44.4K | 0.01% | 1306 |
|
|
2025
Q1 | $534K | Buy |
5,081
+179
| +4% | +$18.8K | 0.01% | 1323 |
|
|
2024
Q4 | $525K | Buy |
4,902
+217
| +5% | +$23.3K | 0.01% | 1301 |
|
|
2024
Q3 | $469K | Buy |
4,685
+279
| +6% | +$27.9K | 0.01% | 1364 |
|
|
2024
Q2 | $371K | Buy |
+4,406
| New | +$371K | ﹤0.01% | 1459 |
|
|
2017
Q4 | – | Sell |
-5,277
| Closed | -$448K | – | 858 |
|
|
2017
Q3 | $448K | Buy |
5,277
+1,342
| +34% | +$114K | 0.02% | 481 |
|
|
2017
Q2 | $298K | Hold |
3,935
| – | – | 0.02% | 561 |
|
|
2017
Q1 | $260K | Buy |
3,935
+642
| +19% | +$42.4K | 0.02% | 567 |
|
|
2016
Q4 | $209K | Buy |
+3,293
| New | +$209K | 0.02% | 592 |
|